Noetix Robotics Reportedly Files Confidentially for Hong Kong IPO
Noetix Robotics, a Chinese developer of humanoid robots, has confidentially filed for an initial public offering in Hong Kong, according to Bloomberg. The offering could raise several hundred million dollars. The Beijing-based startup may list as early as 2027, although the fundraising amount and timetable have not been finalized.
The confidential filing means key details may remain private for now. Companies using confidential filings can prepare a listing without immediately disclosing financial statements, ownership information or the exact size of the offering. Those details may be released at a later stage if the process advances.
Noetix was founded in September 2023, making it a relatively young company in the humanoid robot sector. It develops humanoid robots for consumer, educational and commercial applications. Its lineup includes the Bumi, the N-series and the E-series.
The Bumi is consumer-oriented and was introduced with a starting price of RMB 9,998. That price places the robot below the RMB 10,000 threshold, a level that is unusual for humanoid robots. Many humanoid robots have been designed for industrial, research or specialized uses.
Noetix’s N-series and E-series robots extend its product range beyond the Bumi. The company has not relied on a single product category. Its stated focus covers consumer, education and commercial markets, which require different hardware, software and support.
In March, Noetix secured approximately RMB 1 billion in financing. The round was led by Chendao Capital, an investment platform affiliated with battery maker CATL. The financing gave the company additional resources for product development and commercialization.
The involvement of a CATL-affiliated platform links Noetix to a major battery manufacturer’s investment network. CATL is primarily known for batteries, while Chendao Capital operates as an investment platform. The connection may support supply-chain and manufacturing discussions, although the report did not provide details.
A Hong Kong IPO would give Noetix another source of capital. Private funding rounds can support early development, but public markets can provide longer-term access to capital. The company could use proceeds for research, production and market expansion.
Hong Kong has served as a listing venue for Chinese technology and consumer companies. A humanoid robot listing would add to the range of hardware-focused offerings. The reported plan shows that Noetix is considering public markets alongside private funding.
The reported filing comes as humanoid robot developers require substantial investment. Humanoid robots combine hardware, software, sensors and artificial intelligence. Developing and manufacturing such systems can be capital-intensive before commercial adoption reaches scale.
Noetix has not publicly confirmed the Bloomberg report. Because the filing is confidential, the company’s financial performance and valuation have not been disclosed. The reported 2027 listing timeline is also preliminary and may change.
The report did not identify underwriters, advisers or the exact exchange. It also did not say when the confidential filing was made. Those omissions are typical for confidential filings, which are designed to let companies test investor interest before public disclosure.
If the IPO proceeds, Noetix would gain a higher public profile. A listing could help the company attract partners, customers and employees. It would also test investor appetite for humanoid robot startups in Hong Kong.
Noetix’s product strategy covers several applications. The Bumi targets consumers, while the N-series and E-series may address education and commercial use cases. The company’s ability to scale will depend on demand, manufacturing costs and real-world performance.
The humanoid robot market is still at an early stage of commercial adoption. Companies in the sector are working on hardware reliability, software capabilities and cost reduction. Public listings can provide capital, but they also bring disclosure and performance pressure.
Noetix’s existing products give it a commercial base before a potential listing. The Bumi’s low starting price may help the company reach individual buyers, while the N-series and E-series target other segments. The company’s progress in those markets will shape its public-market story.
For Noetix, the reported filing signals preparation for a more capital-intensive phase. The company has already raised about RMB 1 billion in private financing and launched a low-priced consumer robot. A Hong Kong IPO, if completed, would mark another step in its effort to compete in the humanoid robot market.